AI is rapidly transforming how we create and share knowledge, from research to multimedia content. This shift has sparked concerns about the potential rise of misinformation, especially with AI-generated content that hasn’t undergone rigorous checks. Industries like medicine and science are particularly invested in this topic due to the recent surge in science misinformation, highlighted by the COVID-19 pandemic. This misinformation has undermined healthcare, vaccine confidence, and trust in medical professionals. For life sciences and biopharmaceutical companies, combating medical misinformation is crucial for public engagement and delivering new treatments to patients. However, some experts believe AI can actually help rebuild trust and improve science communication. A recent study in PNAS Nexus suggests that AI-generated summaries enhance public understanding of science and paint scientists in a more favorable light. Francine Carrick, a seasoned science communication veteran, views AI-generated content not as a threat but as an opportunity. She notes that evolving regulations, complex data, and AI are reshaping science communication fundamentally.
Francine Carrick brings over two decades of experience to the evolving landscape of medical communications. Having dedicated nearly seven years to various aspects of business and client strategy at Envision Pharma Group, she then transitioned to BCB Group as Managing Director for Medical Communications in 2024. Her career also includes serving as Chief Commercial Growth Officer for private equity-backed companies, making her intimately familiar with the intricacies of medical communication and the hurdles that have long constrained experts in the field. What truly ignites Carrick’s passion is AI’s capacity to transcend mere acceleration, envisioning it as a catalyst for making medical communications more precise, accessible, and impactful than ever before. She envisions a future where publications dynamically adapt to emerging evidence and tools help researchers unearth insights from vast clinical data. Carrick’s vision is poised to become a reality as she steps into her new role as President of Prezent Vivo, a move that promises to democratize AI access for the life sciences industry.
Carrick’s leadership in healthcare has not gone unnoticed. Previously, Inventive Health recognized her contributions for her work at a leading EVP agency, where she guided scientific, digital, and insights strategists in uncovering profound human and product truths that inspired award-winning creative campaigns. Now, Carrick is set to channel this visionary expertise into establishing Prezent Vivo as a vital resource for life sciences companies and communication agencies, providing them with reliable AI access. The challenge until now has been the lack of AI tools with the necessary scientific depth and rigorous accuracy to scale effectively. Traditional agencies, while an option for outsourcing content tasks, are often slow due to the specialized nature of the work. Prezent Vivo distinguishes itself by integrating a bespoke Large Language Model (LLM), specifically designed to grasp industry context and nuance, with the invaluable insights of domain experts. This fusion marks a pivotal moment, and for Carrick, it’s the realization of a long-held dream: a solution that empowers the best minds in MedComms to deliver even greater value to their clients. She sees MedComms undergoing a profound transformation, with leading agencies seeking to elevate their experts.
Prezent Vivo is poised to revolutionize medical communications by eliminating the compromises that have historically limited AI adoption in the industry. It achieves this by seamlessly integrating purpose-built AI with embedded domain experts, resulting in communications that are not only rapid and cost-effective but also scientifically precise and fully compliant. The core differentiator of Prezent Vivo lies in its unique ability to fuse two critical capabilities. First, Astrid AI, an agent meticulously designed for Life Sciences communication, has been trained on brand compliance requirements, regulatory language, clinical evidence structures, and the nuances of commercial and medical strategy. This advanced AI is then complemented by the expertise of human domain specialists, including presentation engineers, MedComms engineers, and medical writers. These human experts provide the essential scientific judgment and strategic narrative, ensuring that life science organizations receive high-stakes communications that are audience-ready and utterly reliable. This powerful synergy finally allows the industry to harness the speed of AI-powered communication at scale, all without compromising on precision or compliance.
Prezent Vivo’s launch disrupts the traditional agency model, building upon the original Prezent platform’s success in supporting presentation goals across various industries. Vivo operates as an adjacent yet distinct entity, offering a broader spectrum of communication outputs while providing much deeper domain expertise tailored specifically for the life science and biopharma sectors. This newly introduced platform delivers AI-powered communication with remarkable speed and scalability across the entire content deliverable spectrum. This encompasses the full product lifecycle, from congress posters and data visualization to scientific documents, brochures, MSL narrative decks, advisory board materials, and even national sales meeting content. Prezent Vivo promises to deliver both speed and scientific rigor throughout the product lifecycle, potentially reducing costs for biopharma companies by a significant 35% to 85% compared to engaging traditional agencies. Importantly, while companies can directly utilize the platform, Prezent Vivo has been designed with agencies in mind. It’s not intended to replace MedComms agencies but rather to enhance their profitability. By entrusting AI with production tasks, agencies can free their experts to focus on crucial scientific strategy. This innovative approach enables agencies to manage three times the project volume per writer without needing to increase their headcount.
Ultimately, the goal is to empower experts in the life sciences industry to communicate with clarity and effectively combat disinformation. While concerns about compliance and accuracy have previously restricted the use of AI in creating communication materials, Prezent Vivo offers a compelling glimpse into how this technology can amplify the voices of scientific experts and significantly improve patient engagement. This new era promises a future where AI and human expertise collaborate seamlessly, ensuring that vital scientific information is disseminated accurately, efficiently, and with maximum impact, ultimately benefiting patients and advancing healthcare worldwide.